WGRX
Wellgistics Health, Inc.
3.00$
-14.7%
vs. previous close
Closing price · As of: Aug 15, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 100.0% | 29.1% | 22.9% | 26.1% | 26.5% | 28.5% | 24.9% | 24.3% | 9.3% | 9.2% | 17.2% | |
| – | 0.4% | 2.6% | 4.6% | 1.4% | 1.8% | 4.3% | 0.8% | 8.0% | 0.1% | 0.2% | 7.5% | |
| – | 0.4% | 2.6% | 4.6% | 1.4% | 1.8% | 4.3% | 0.8% | 8.0% | 0.1% | 0.2% | 7.5% | |
| – | 99.6% | 6.0% | 3.6% | 5.9% | 6.5% | 6.8% | 7.4% | 2.1% | 3.7% | 3.3% | 3.6% | |
| – | 0.0% | 18.7% | 14.0% | 17.7% | 16.6% | 16.8% | 16.7% | 14.2% | 5.4% | 5.7% | 4.6% | |
| – | 0.0% | 39.0% | 32.3% | 26.2% | 28.3% | 27.9% | 29.9% | 30.7% | 46.6% | 47.1% | 43.3% | |
| – | – | 26.3% | 37.7% | 42.4% | 39.0% | 37.7% | 39.2% | 35.0% | 33.9% | 33.1% | 29.5% | |
| – | 957.2% | 100.0% | 102.2% | 82.0% | 88.3% | 92.3% | 98.3% | 87.2% | 140.9% | 150.0% | 159.5% | |
| – | 853.8% | 40.3% | 38.4% | 59.4% | 66.4% | 79.6% | 78.2% | 62.0% | 97.8% | 106.9% | 120.3% | |
| – | 103.4% | 15.9% | 12.5% | 17.1% | 21.9% | 31.7% | 25.7% | 24.5% | 38.2% | 52.8% | 60.4% | |
| – | 307.0% | 13.7% | 10.7% | 12.0% | 11.0% | 14.1% | 17.5% | 19.8% | 38.4% | 39.8% | 38.5% | |
| – | 103.4% | 34.7% | 36.7% | 20.5% | 20.0% | 11.0% | 18.6% | 23.9% | 41.4% | 41.8% | – | |
| – | -857.2% | 0.0% | -2.2% | 18.0% | 11.7% | 7.7% | 1.7% | 12.8% | -40.9% | -50.0% | -59.5% | |
| – | -857.3% | -9.8% | -25.5% | -9.8% | -17.0% | -72.7% | -90.1% | -157.6% | -364.5% | -394.2% | -418.6% | |
| – | 276.6% | 2.8% | 2.3% | 1.9% | 1.8% | 1.8% | 2.3% | 2.8% | 4.7% | 4.7% | 7.9% |
Data as of: August 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.